Navigation Links
Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
Date:1/15/2008

CAMBRIDGE, Mass., Jan. 15 /PRNewswire/ -- Tolerx, Inc., a biopharmaceutical company engaged in the discovery and development of novel therapies for the treatment of immune-mediated diseases, announced today the successful completion of a Phase Ib clinical study of TRX1, a novel humanized anti-CD4 monoclonal antibody (MAb), in subjects with refractory cutaneous lupus erythematosus (CLE). The Phase Ib study was designed to assess the safety, tolerability, and pharmacokinetics of TRX1. Tolerx has received a milestone payment from Genentech, Inc. in conjunction with the completion of this study.

Tolerx and Genentech entered into a collaboration in 2002 to develop and commercialize certain anti-CD4 monoclonal antibodies, including TRX1. Pursuant to this arrangement, Genentech may undertake the further development, manufacturing, and commercialization of those anti-CD4 molecules in any indication. The agreement provides for Tolerx to potentially receive development and regulatory milestone payments. In addition, Tolerx can receive royalties on worldwide net sales of those anti-CD4 antibodies and has the option to participate in a loss and profit sharing arrangement with Genentech in the United States.

Dr. Douglas J. Ringler, President and Chief Executive Officer of Tolerx, commented, "This is an exciting next step in our effort to define new treatment paradigms for patients afflicted with immune-mediated diseases. The clinical data from the Phase Ib study provides us with optimism for the continued advancement of our anti-CD4 antibody programs, and we remain excited about our collaboration with Genentech."

About TRX1

TRX1 is a novel humanized monoclonal antibody (MAb) that binds to the CD4 receptor found on both T effector cells and T regulatory cells. TRX1 is expected to block the activation and function of T effector cells and to favor dominance of T regulatory cells. This process, referred to as down regulation of the immune system, r
'/>"/>

SOURCE Tolerx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
2. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
3. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
4. Cethromycin Achieves All Endpoints in Second Pivotal Phase III Trial for Treatment of Pneumonia
5. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
6. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
7. Medarex to Receive Milestone Payment from Amgen
8. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
9. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
10. Isis Earns $5 Million Milestone Payment From Ortho-McNeil, Inc. for Initiation of Phase 1 Study of ISIS 325568
11. FASgen Announces Significant Milestone in Its Cancer Drug Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ), announced today ... highly specialized pharmacy and infusion services company that provides ... based in Cincinnati, Ohio . With ... capabilities will make Diplomat one of the nation,s largest ... dedicated to personalized medication therapies for patients with chronic ...
(Date:4/1/2015)... Eraser Clinic Laser Tattoo Removal in Austin, ... in the area to offer laser tattoo removal treatments with ... can treat the widest range of ink colors, including the ... "Our focus at Eraser Clinic is to run the ... and that happens by giving our clients the results they ...
(Date:4/1/2015)... , April 1, 2015  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... the position of Vice President, General Counsel and Corporate ... directly to Pat Mackin , President and Chief ... is tremendously talented and has extensive legal experience in ...
Breaking Medicine Technology:Diplomat Completes Acquisition of BioRx 2Diplomat Completes Acquisition of BioRx 3Diplomat Completes Acquisition of BioRx 4Eraser Clinic Is The First To Offer Trinity Laser Tattoo Removal In Austin, TX 2CryoLife Appoints Jean Holloway as General Counsel 2CryoLife Appoints Jean Holloway as General Counsel 3
... May 5, 2011 Ridge Diagnostics, Inc., a ... at the 6th Annual Neurotech Investing and Partnering Conference to ... Hotel on May 9th and 10th.   Ms. ... panel entitled "Next Generation Psychiatry" lead by Dr. Manuel Lopez-Figueroa, ...
... INDIANAPOLIS, May 5, 2011 Eli Lilly and Company ... an Indianapolis-based nonprofit that supports bold, new education reform, ... What Works campaign. Grow What Works seeks to raise ... working in Indianapolis, enabling them to serve more students ...
Cached Medicine Technology:Ridge Diagnostics, Inc. CEO to Speak at Neurotech Investing and Partnering Conference 2Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 2Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 3Eli Lilly and Company Invests $2.5 Million to Launch The Mind Trust's Grow What Works Campaign 4
(Date:4/1/2015)... It all began at home in the kitchen ... on a mission to create a line of skincare for ... could trust. Now, Shoosha Truly Organic is the only complete ... all products contain a minimum 95% certified organic ingredients, for ... considered to be 40% thinner than adults and of course ...
(Date:4/1/2015)... Seattle, WA (PRWEB) April 01, 2015 ... management and patient scheduling platform, today announced that CEO ... 2015 Annual HIMSS Conference & Exhibition in ... Outpatient Revenue Growth with Better Provider Care Coordination Strategies ... April 16 at 12 p.m. CDT. More than 38,000 ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 GrassrootsHealth, ... announcing two continuing medical education (CME) courses about ... help practitioners become more confident in measuring, prescribing, ... After completion of these CME courses, practitioners can ... The CME courses available are “Vitamin D, Sunshine, ...
(Date:4/1/2015)... April 01, 2015 Like a mosaic ... the scientific understanding of the potential causes of rosacea. ... the National Rosacea Society (NRS) to educate the public ... facial disorder now estimated to affect more than 16 ... medical research on rosacea through its patient-funded research grants ...
(Date:4/1/2015)... Health Advocate™, Inc., the nation’s leading healthcare ... Corporation, today launched its new Health and Wellness Blog. ... the Health Advocate member website, features timely and reliable ... , “We’re pleased to introduce this new blog and ... Rosen, Executive Vice President, Health Advocate. “The blog is ...
Breaking Medicine News(10 mins):Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 2Health News:Just in Time for Earth Day This April, Shoosha Truly Organic’s Skincare Line Soothes and Protects Mom and Baby’s Sensitive Skin with Pure, Simple and Organic Ingredients 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:GrassrootsHealth Launches CME Courses about Vitamin D 2Health News:GrassrootsHealth Launches CME Courses about Vitamin D 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:Health Advocate Launches New Health and Wellness Blog 2
... not maintain their existence without thousands of proteins ... proteins can cause disease , the study of ... development of drugs and treatments for numerous disorders. ... the cellular function of numerous proteins is still ...
... parent smoking have five times as much cotinine, a nicotine ... , according to a report published in the journal, Archives ... by researchers from the University of Leicester. They looked at ... smoked and 33 with nonsmoking parents) and found that having ...
... of print in the Journal of Neurology Neurosurgery and Psychiatry, ... involuntary eye spasm called primary late onset blepharospasm, which ... ,The effect was proportional to the amount of ... needed for the protective effect to be seen. The age ...
... very poor sleep quality and often have troubling ... PhD, RN . The study provides the first ... cancer patients using continuous polysomnography (PSG) data, deemed ... sleep. It involved 114 advanced cancer patients with ...
... in JAMA, a review of previous studies indicates that ... provides substantial benefit to HIV-negative women in Africa , ... ,In malaria-endemic regions, the burden of disease ... are particularly vulnerable to the adverse effects of malaria ...
... the government to vaccinate all girls from the age 11 ... and Immunisation want the vaccination against human papilloma virus ... there is expected to be a "catch-up" programme for those ... Cervarix have been developed to protect against strains of HPV ...
Cached Medicine News:Health News:Weizmann Researchers Developed Control Switch for Protein Activity 2Health News:Weizmann Researchers Developed Control Switch for Protein Activity 3Health News:Smokers Blow Their Infants Health into Thin Air 2Health News:Eyelid Spasm can Be Prevented by Coffee Drinking 2Health News:Advanced Cancer Patients Have Sleep Disorders 2Health News:Effective Treatment for Malaria Control 2Health News:Effective Treatment for Malaria Control 3Health News:Cervical Cancer Vaccine for the 12 Year Old 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: